在乌干达的多药耐药M.结核病的rpoA/B/C基因中发生补偿突变的模式
David Patrick Kateete1,2, Shakira Namakula1,2, Edgar Kigozi1,2
1Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
PloS one
|December 4, 2025
概括
RNA聚合酶基因的补偿突变在乌干达的耐利芬素结核菌中很常见. 这些突变有助于耐药菌株保持健康,影响结核病治疗策略.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 在Mycobacterium结核病中,利芬素耐药性往往与rpoB基因的突变有关.
- RNA聚合酶 (RNAP) 基因中的二次突变可以补偿抗利芬素耐药性的健康成本.
- 了解这些补偿突变对于治疗耐药结核病至关重要.
研究的目的:
- 调查乌干达临床孤立的抗利芬辛耐药M.结核病RNAP基因中补偿突变的流行率和模式.
- 为了确定rpoA,rpoB,rpoC和rpoD中的特定突变,这些突变可能会抵消体能缺陷.
主要方法:
- 采用了全基因组测序和桑格尔DNA测序.
- 分析了52种M.结核病临床分离物 (20种对药物敏感,32种对多种药物耐药).
- 专注于rpoB rifampicin-resistance-determining region (RRDR) 和其他RNAP基因 (如rpoC) 中的突变.
主要成果:
- 在75%的MDR-TB隔离物中,在rpoB/RRDR中发现了高水平的利芬辛耐药性突变.
- 在RRDR之外的rpoB中发现了两个假定的补偿突变 (Gln490Arg和Lys1025Glu).
- 在63%具有rpoB突变的MDR-TB分离物中存在rpoC的非同义突变,特别是rpoC/Gly594Glu和rpoC/Val483Ala.
结论:
- 补偿性突变在乌干达的抗利芬辛M.结核病分离体中普遍存在.
- rpoC/Gly594Glu和rpoC/Val483Ala是观察到的最常见的补偿突变.
- 需要进一步的研究来了解这些突变对菌株适应性和传播的影响,特别是在HIV-TB联合感染的环境中.
相关概念视频
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Mutations in Microorganisms
479
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
479
Pulmonary Tuberculosis I
806
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
806
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K


